Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study

• Published in: International journal of molecular sciences Vol. 25; no. 17; p. 9139
• Main Authors: Moschetti, Marta, Lo Curto, Alessia, Giacomarra, Miriam, Francofonte, Daniele, Zizzo, Carmela, Messina, Elisa, Duro, Giovanni, Colomba, Paolo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.09.2024
• Subjects: Adult; alpha-Glucosidases - genetics; Cardiomyopathy; Disease; Enzymes; Female; Genetic counseling; Genetic testing; Genotype & phenotype; Glycogen Storage Disease Type II - genetics; Humans; Italy; Kinases; Male; Medical screening; Middle Aged; Mutation; Patients; Respiratory failure; Italy; Pompe disease; metabolic myopathy; mutation spectrum; misdiagnosis; therapeutic procedures
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25179139

Studying a patient with Pompe disease (PD) is like opening Pandora’s box. The specialist is faced with numerous clinical features similar to those of several diseases, and very often the symptoms are well hidden and none is associated with this rare disease. In recent years, scientific interest in this disease has been growing more and more, but still no symptom is recognized as key to a correct diagnosis of it, nor is there any specific disease marker to date. New diagnostic/therapeutic proposals on disease allow for the diffusion of knowledge of this pathology for timely diagnosis of the patient. Due to unawareness and difficulty in diagnosis, many adults with PD are diagnosed with great delay. In this article, we report and discuss current knowledge of PD and provide new data from work conducted on a cohort of 2934 Italian subjects recruited in recent years. A genetic analysis of the GAA gene was performed on patients with significant clinical signs and pathological enzyme activity to define the genetic profile of subjects. This identified 39 symptomatic PD subjects with low acid alpha-glucosidase enzyme activity and the presence of two causative mutations in GAA gene regions. Furthermore, 22 subjects with genetic variants of uncertain significance (GVUS) were identified.